...
机译:MiR-891B的PARP1的下调使人乳腺癌细胞敏化为烷基化化学治疗药物
Shandong Univ Qilu Hosp Dept Breast Surg Jinan 250012 Shandong Peoples R China;
Binzhou Med Univ Dept Rehabil Med Affiliated Hosp Binzhou 256603 Peoples R China;
Binzhou Med Univ Dept Thyroid &
Breast Surg Affiliated Hosp 661 Huangheer Rd Binzhou 256603;
Binzhou Med Univ Dept Thyroid &
Breast Surg Affiliated Hosp 661 Huangheer Rd Binzhou 256603;
Binzhou Med Univ Dept Thyroid &
Breast Surg Affiliated Hosp 661 Huangheer Rd Binzhou 256603;
Binzhou Med Univ Dept Thyroid &
Breast Surg Affiliated Hosp 661 Huangheer Rd Binzhou 256603;
Breast cancer; MicroRNA-181b; PARP1; Alkylating chemotherapeutic agent; MNNG;
机译:MiR-891B的PARP1的下调使人乳腺癌细胞敏化为烷基化化学治疗药物
机译:CDK4 / 6抑制剂对PARP1转录的下调通过削弱OGG1依赖性碱基切除修复而使人肺癌细胞对抗癌药物诱导的死亡敏感
机译:小ber碱减弱XRCC1介导的碱基切除修复,并使乳腺癌细胞对化疗药物敏感
机译:三维硅微结构研究抗癌药物对人乳腺癌细胞的作用
机译:N-甲基嘌呤DNA糖基化酶(MPG)的腺病毒过表达使乳腺癌细胞对烷化剂化学疗法敏感。
机译:朝鲜蓟多酚通过ROS介导的瓣内切核酸酶1下调使人乳腺癌细胞对化疗药物敏感。
机译:CDK4 / 6抑制剂对paRp1转录的下调通过OGG1依赖性碱基切除修复使人肺癌细胞对抗癌药物诱导的死亡敏感
机译:DNa碱基切除修复(BER)和癌症基因治疗:使用人类N-mythlpurien DNa糖基化酶(mpG)使乳腺癌细胞对低剂量化疗敏感